Actively Recruiting
Impact of Vaccine Funding by the National Health Insurance on Vaccination Coverage Among Patients Targeted by Current Vaccination Recommendations and Followed in Outpatient Consultations
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-04-08
2920
Participants Needed
6
Research Sites
84 weeks
Total Duration
On this page
Sponsors
A
Assistance Publique - Hôpitaux de Paris
Lead Sponsor
A
Agence régionale de santé Ile de France
Collaborating Sponsor
AI-Summary
What this Trial Is About
The objective of our study is to evaluate the impact of vaccine funding for patients seen in outpatient consultations within four healthcare institutions in the Ile-de-France region in France, made possible through the establishment of a tripartite agreement between the hospital group, the Île-de-France Regional Health Agency (ARS IDF), and the Primary Health Insurance Fund (CPAM).
CONDITIONS
Official Title
Impact of Vaccine Funding by the National Health Insurance on Vaccination Coverage Among Patients Targeted by Current Vaccination Recommendations and Followed in Outpatient Consultations
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals aged 18 years or older
- Individuals followed in outpatient consultations within a participating healthcare institution
- Individuals eligible for pneumococcal vaccination according to current French recommendations
- Individuals covered by long-term illness coverage (ALD), complementary universal health coverage (C2S), or state medical aid (AME)
- Women aged 18 years or older who have had at least one outpatient consultation from 20 weeks of pregnancy in a participating maternity ward
- Women in the immediate postpartum period after delivering one or more live children after 36 weeks of gestation
- Women covered under maternity insurance from the sixth month of pregnancy until 12 days after delivery
- Vaccinating healthcare providers working in participating departments or centers
You will not qualify if you...
- Individuals seen in settings other than outpatient consultations such as day hospital, week hospital, conventional hospitalization, or International Vaccination Center
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
COCHIN HOSPITAL - Assistance Publique-Hôpitaux de Paris (APHP)
Paris, IDF, France, 75014
Actively Recruiting
2
Sud Seine Et Marne Hospital
Fontainebleau, France, 77300
Not Yet Recruiting
3
Sud Seine Et Marne Hospital
Montereau-Fault-Yonne, France, 77130
Not Yet Recruiting
4
Sud Seine Et Marne Hospital
Nemours, France, 77140
Not Yet Recruiting
5
Rambouillet Hospital
Rambouillet, France, 78120
Not Yet Recruiting
6
Delafontaine Hospital
Saint-Denis, France, 93200
Not Yet Recruiting
Research Team
M
Marie LACHATRE, MD
CONTACT
M
Marie BENHAMMANI-GODARD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here